N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-phenylacetamide | CAS:132628-16-1

We serve N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-phenylacetamide CAS:132628-16-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-phenylacetamide

Chemical Name:N-[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-oxo-3H-purin-2-yl]-2-phenylacetamide
CAS.NO:132628-16-1
Synonyms:N2-(phenylacetyl)-guanosine
N-(9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)-2-phenylacetamide
N-(Phenylacetyl)guanosine
2-N-(phenylacetyl)guanosine
Molecular Formula:C18H19N5O6
Molecular Weight:401.37300
 
Physical and Chemical Properties:
Density:1.74
Melting point:189ºC
Index of Refraction:1.784
 
Specification:
Appearance:White to off-white powder
Assay(HPLC):≥99.0%
MOisture:≤5.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of pharmaceutical.



Contact us for information like N2-(phenylacetyl)-guanosine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-[9-[(2R,3R,4S,5R)-3,4-Dihydroxy-5-(Hydroxymethyl)Oxolan-2-Yl]-6-Oxo-3H-Purin-2-Yl]-2-Phenylacetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-N-(phenylacetyl)guanosine Use and application,2-N-(phenylacetyl)guanosine technical grade,usp/ep/jp grade.


Related News: After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API.2',3',5'-Triacetyl -azacytidine manufacturer Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans. Several known coronaviruses are circulating in animals that have not yet infected humans.2,3-Diethyl-5-methylpyrazine supplier ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.1,5-dichloro-2-methyl-4-(trifluoromethyl)benzene vendor The new rules started Saturday — however if you’re an Australian citizen, permanent resident or their immediate family, or an aircrew member who has been using appropriate protective equipment, you’re exempt.A Phase 1/2 trial of the combination therapy has been fully enrolled, and the preliminary efficacy and safety data was presented at The American Society of Hematology (ASH) Annual Meeting in December 2018.